Evidence map›Paper›PMID 41612198›Full record

ArticleBMC medical research methodology2026

Where did I leave my systematic review protocol, and what should it contain regarding Trial Sequential Analysis?

Mark Aninakwah Asante, Vibeke Wagner, Sigurlaug Hanna Hafliðadóttir, Buddheera Wmb Kumburegama, Elisabeth Buck Pedersen, Johanne Pereira Ribeiro, Julie Perrine Schaug, Joachim Birch Milan, Markus Harboe Olsen, Christina Madsen and 2 more

Abstract read
In one paragraph

Article in BMC medical research methodology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mark Aninakwah AsanteCopenhagen Trial Unit, Centre for Clinical Intervention Research, The Capital Region, Copenhagen University Hospital - Rigshospitalet, Blegdamsvej 9, Copenhagen, 2100, Denmark. asantemark68@gmail.com.
Vibeke WagnerDepartment of Brain and Spinal Cord Injury, Neuroscience Centre, Copenhagen University Hospital - Rigshospitalet, Valdemarsvej 23, Glostrup, 2600, Denmark.
Sigurlaug Hanna HafliðadóttirBjarg Rehabilitation Center, Bugðusíðu 1, Akureyri, 603, Iceland.
Buddheera Wmb KumburegamaCopenhagen Trial Unit, Centre for Clinical Intervention Research, The Capital Region, Copenhagen University Hospital - Rigshospitalet, Blegdamsvej 9, Copenhagen, 2100, Denmark.
Elisabeth Buck PedersenDepartment of Brain and Spinal Cord Injury, Neuroscience Centre, Copenhagen University Hospital - Rigshospitalet, Valdemarsvej 23, Glostrup, 2600, Denmark.
Johanne Pereira RibeiroCenter for Evidence-Based Psychiatry, Psychiatric Research Unit, Psychiatry Region Zealand, Fælledvej 6, Slagelse, Region Zealand, 4200, Denmark.
Julie Perrine SchaugCenter for Evidence-Based Psychiatry, Psychiatric Research Unit, Psychiatry Region Zealand, Fælledvej 6, Slagelse, Region Zealand, 4200, Denmark.
Joachim Birch MilanCopenhagen Trial Unit, Centre for Clinical Intervention Research, The Capital Region, Copenhagen University Hospital - Rigshospitalet, Blegdamsvej 9, Copenhagen, 2100, Denmark.
Markus Harboe OlsenCopenhagen Trial Unit, Centre for Clinical Intervention Research, The Capital Region, Copenhagen University Hospital - Rigshospitalet, Blegdamsvej 9, Copenhagen, 2100, Denmark.
Christina MadsenCenter for Evidence-Based Psychiatry, Psychiatric Research Unit, Psychiatry Region Zealand, Fælledvej 6, Slagelse, Region Zealand, 4200, Denmark.
Christian Gunge RiberholtCopenhagen Trial Unit, Centre for Clinical Intervention Research, The Capital Region, Copenhagen University Hospital - Rigshospitalet, Blegdamsvej 9, Copenhagen, 2100, Denmark.
Christian GluudCopenhagen Trial Unit, Centre for Clinical Intervention Research, The Capital Region, Copenhagen University Hospital - Rigshospitalet, Blegdamsvej 9, Copenhagen, 2100, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPublishing a protocol before starting a systematic review is necessary to ensure data integrity and trustworthiness of results. Trial Sequential Analysis (TSA) is a program and analysis method to control random type I and type II errors often used in systematic reviews (having a protocol in some form) and meta-analyses publications (having no protocol). We scrutinised protocols for systematic reviews and meta-analyses reports to examine their quality and transparency focusing on TSA parameters.

methodsWe searched Medline and the Cochrane Database of Systematic Reviews from 1 January 2018 to 31 December, 2021 for published systematic reviews and meta-analysis reports that included a TSA. We included reports that had at least two randomised clinical trials analysed in a forest plot plus in a TSA. Two independent researchers extracted data to assess coherence between the protocol and its systematic review. Disagreements were resolved through discussion or arbitration.

resultsWe included 270 systematic reviews with pre-published protocols and 274 meta-analyses without protocols. Among the systematic reviews, 135 (50%) planned to perform TSA in their protocols (112 dichotomous and 23 continuous outcomes). TSA parameters between protocols and published reviews were often inconsistent. For dichotomous outcomes, consistency was highest for alpha (50.9%) and lowest for power (1.8%). For continuous outcomes, consistency was minimal across all parameters. Statistically significant deviations between planned and actual TSA values were observed for statistical power (mean increase 8.95%; 95% CI 7.43% to 10.47%; p < 0.001) and heterogeneity (43.8% vs. 57.1%; p = 0.048) in dichotomous outcomes. Systematic reviews with predefined TSA parameters in protocols demonstrated significantly better reporting of the proportion of participants with the outcome in the control groups, alpha, and heterogeneity compared to those without protocol information. These patterns persisted when including the meta-analyses reports. Systematic reviews with continuous outcomes showed similar trends, though differences were not statistically significant.

conclusionTSA is often neglected in systematic reviews protocols and when planned the TSA parameters are inconsistently reported and followed. Predefined protocols improve transparency and reporting, and should be required to enhance reproducibility, reduce bias, and prevent research waste in systematic reviews.

Indexed as

Meta-Analysis as TopicRandomized Controlled Trials as TopicResearch DesignSystematic Reviews as TopicHumansContinuous outcomesDichotomous outcomesMeta-analysisMethodologyProtocolSystematic reviewTrial sequential analysis

Identifiers

PMID41612198
PMCPMC12924246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.